Skip to main content

Table 2 Correlation of FGF21 with anthropometric and biochemical variables

From: Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients

Covariables

Women

Men

r

P

r

P

Age(year)

0.031

0.647

−0.011

0.858

Diabetes duration(year)

−0.030

0.662

−0.015

0.805

Body mass index(kg/cm2)

0.160

0.018

0.081

0.179

Waist circumference(cm)

0.188

0.005

0.074

0.218

Systolic blood pressure(mmHg)

0.200

0.003

−0.036

0.551

Diastolic blood pressure(mmHg)

0.176

0.009

−0.036

0.557

Fasting plasma glucose(mmol/L)

0.005

0.945

−0.003

0.958

2 h postprandial plasma glucose(mmol/L)

0.073

0.290

−0.092

0.139

Fasting C-peptide(ng/ml)

0.168

0.017

0.102

0.106

2-h postprandial C peptide(ng/ml)

0.149

0.034

0.014

0.845

Total cholesterol(mmol/L)

0.036

0.606

0.088

0.160

Triglyceride(mmol/L)

0.245

<0.001

0.21

0.001

High-density lipoprotein cholesterol(mmol/L)

−0.192

0.006

−0.091

0.147

Low-density lipoprotein cholesterol(mmol/L)

−0.044

0.524

−0.007

0.906

Glycated hemoglobin A1c(%)

0.047

0.493

0.057

0.366

Glycated serum albumin(%)

−0.001

0.985

−0.011

0.865

C reactive protein(mg/L)

0.150

0.032

0.222

<0.001

Femoral intima-media thickness(mm)

0.151

0.048

0.022

0.709